Key result
Tanshinone IIA alleviates post-MI cardiac fibrosis and improves ventricular remodeling by downregulating miR-205-3p.
Why the study?
Does Tanshinone IIA improve ventricular remodeling and alleviate cardiac fibrosis following myocardial infarction?
Does Tanshinone IIA improve ventricular remodeling and alleviate cardiac fibrosis following myocardial infarction?
Tanshinone IIA demonstrates potential in alleviating cardiac fibrosis and improving ventricular remodeling after myocardial infarction via regulation of miR-205-3p.
Answers are grounded in this paper and cite their sources.
Should not change post-MI care; hypothesis-generating for Tanshinone IIA in human remodeling.
OBJECTIVE: L of TSN in cardiac fibroblasts, relative levels of miR-205-3p, Col1a1, and Col3a1 were detected by quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS: 1 on downregulating miR-205-3p and upregulating Col1a1 and Col3a1 in cardiac fibroblasts. CONCLUSIONS: 1, TSN alleviates cardiac fibrosis and improves ventricular remodeling following MI.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2021) studied this question. Tanshinone IIA alleviates cardiac fibrosis and improves ventricular remodeling following myocardial infarction by downregulating miR-205-3p and upregulating Col1a1 and Col3a1.
Synapse has enriched 10 related papers. Consider them for comparative context: